Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Balsalazide Disodium Capsules USP, 750 mg.

Related Keywords

United States ,Ahmedabad ,Gujarat ,India , ,Cadila Healthcare ,Zydus Lifesciences ,Drug Administration ,Balsalazide Disodium Capsules ,Lifesciences Limited ,United States Food ,Colazal Capsules ,Cadila Healthcare Limited ,Zyduslifesciences ,Ine010b01027 ,Finalapproval ,Usfda ,Balsalazidedisodiumcapsules ,